Abstract
We studied the expression of Down’s syndrome cell adhesion molecule (DSCAM) in Down’s syndrome (DS) and control brains, using antisera against peptide fragments of DSCAM. On Western blots of human, mouse and rat brain homogenates, the antisera recognized a product at approximately 200 kDa. In the brain of a 2-year-old patient with DS, Western blotting revealed an overexpression of DSCAM compared to an age-matched control. Immunohistochemistry demonstrated DSCAM in the cerebral and cerebellar white matter of both control and DS subjects, in accordance with the temporal and spatial sequence of myelination. In DS brains, immunoreactivity for DSCAM, compared to that for controls, was enhanced in the Purkinje cells at all ages, and in the cortical neurons during adulthood. In demented DS patients, DSCAM immunoreactivity was observed in the core and periphery of senile plaques. The pattern of DSCAM expression suggests that it may play a role as an adhesion molecule regulating myelination. The overexpression of DSCAM may also play a role in the mental retardation and the precocious dementia of DS patients, although the mechanism of neuronal dysfunction is undetermined.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 13 December 1999 / Revised, accepted: 23 February 2000
Rights and permissions
About this article
Cite this article
Saito, Y., Oka, A., Mizuguchi, M. et al. The developmental and aging changes of Down’s syndrome cell adhesion molecule expression in normal and Down’s syndrome brains. Acta Neuropathol 100, 654–664 (2000). https://doi.org/10.1007/s004010000230
Issue Date:
DOI: https://doi.org/10.1007/s004010000230